Beta Bionics, Inc. (BBNX) vs iRadimed Corporation (IRMD)

Beta Bionics, Inc. and iRadimed Corporation are both Medical Devices companies. Beta Bionics, Inc. and iRadimed Corporation are of similar size ($1.2B and $1.1B). Beta Bionics, Inc. has negative trailing earnings, so its P/E is not meaningful; iRadimed Corporation trades at 47.1×. Beta Bionics, Inc. grew revenue faster over the last twelve months: 52.5% against 11.2%. iRadimed Corporation has the higher net margin (26.7% vs −61.3%) and the higher return on invested capital (40.4% vs −68.5%). Across the 16 metrics below, iRadimed Corporation leads on 11 and Beta Bionics, Inc. on 5.

Valuation

Metric BBNX IRMD Medical Devices median
P/E n/m 47.12 22.18
P/S 8.05 12.70 2.70
P/B 3.74 10.78 2.46
Price to free cash flow n/m 46.51 22.53
EV/EBITDA n/m 35.54 11.78
EV/Sales 6.53 12.01 2.38
Earnings yield (7.67%) 2.12% (8.22%)
Free cash flow yield (35.29%) 2.15% (7.80%)

Profitability

Metric BBNX IRMD Medical Devices median
Gross margin 58.31% 75.86% 56.01%
Operating margin (69.75%) 31.92% (15.03%)
Net margin (61.32%) 26.70% (20.40%)
Free cash flow margin (284.13%) 28.43% (7.24%)
Return on equity (26.16%) 23.52% (15.32%)
Return on assets (23.45%) 20.82% (19.72%)
Return on invested capital (68.47%) 40.36% (10.33%)

Growth

Metric BBNX IRMD Medical Devices median
Revenue growth (TTM) 52.54% 11.21% 8.80%
EPS growth (last fiscal year) 78.95% 16.67% —
Revenue growth, 5-year CAGR — 21.45% 15.23%
Net income growth, 5-year CAGR — 75.02% 0.00%

Health

Metric BBNX IRMD Medical Devices median
Debt to equity 0.00 0.00 0.07
Current ratio 8.88 9.46 2.50
Net debt to EBITDA 3.19 (1.87) 0.49

Dividend

Metric BBNX IRMD Medical Devices median
Dividend yield — 0.32% 0.94%
Payout ratio — 0.00 0.00

Size

Metric BBNX IRMD Medical Devices median
Market cap 1.17b 1.09b 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack